Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patients
about
Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patients
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacokinetics and safety of ...... ciency virus-infected patients
@ast
Pharmacokinetics and safety of ...... ciency virus-infected patients
@en
type
label
Pharmacokinetics and safety of ...... ciency virus-infected patients
@ast
Pharmacokinetics and safety of ...... ciency virus-infected patients
@en
prefLabel
Pharmacokinetics and safety of ...... ciency virus-infected patients
@ast
Pharmacokinetics and safety of ...... ciency virus-infected patients
@en
P2093
P2860
P356
P1476
Pharmacokinetics and safety of ...... ciency virus-infected patients
@en
P2093
Natarajan J
Piscitelli SC
Williams RR
P2860
P304
P356
10.1128/AAC.43.9.2323
P407
P577
1999-09-01T00:00:00Z